Recalls for Pharmacology

Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Requires Drug Interaction Studies
10/22/2015 Medical Recall

Prescribers and patients should consider separating Kayexalate dosing from other medications taken by mouth by at least 6 hours.

  • Category
    Pharmacology
Avycaz (ceftazidime and avibactam): Drug Safety Communication - Dose Confusion and Medication Errors
09/22/2015 Medical Recall

FDA revised the labels to indicate that each vial contains Avycaz 2.5 gram, equivalent to ceftazidime 2 gram and avibactam 0.5 gram.

  • Company:
    Avycaz
Compounded Drugs Stored in Becton-Dickinson (BD) 3 ml and 5 ml Syringes: FDA Warning - Do Not Use
08/18/2015 Medical Recall

Preliminary information indicates that drugs stored in these syringes may lose potency over a period of time due to a possible interaction with the rubber stopper in the syringe.

  • Category
    Pharmacology
Hydrochlorothiazide Tablets by Unichem Pharmaceuticals (USA), Inc: Recall - Potential Presence of Foreign Tablets Contamination
08/01/2015 Medical Recall

Missing a dose of Hydrochlorothiazide could result in uncontrolled blood pressure or swelling caused by excess fluid (edema).

  • Company:
    Unichem
Zerbaxa (ceftolozane and tazobactam): Drug Safety Communication - FDA Cautions about Dose Confusion and Medication Errors
05/20/2015 Medical Recall

Can lead to to administration of more drug than was prescribed.

  • Company:
    Zerbaxa
Arize: Public Notification - Undeclared Drug Ingredient
08/11/2014 Medical Recall

Undeclared sulfoaildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.

  • Company:
    Arize
Herbal Vigor Quick Fix: Public Notification - Undeclared Drug Ingredient
08/11/2014 Medical Recall

Undeclared tadalafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.

  • Category
    Pharmacology
Ibuprofen and Oxcarbazepine Tablets by American Health Packaging: Recall - Mislabeled Packaging
07/21/2014 Medical Recall

Failure to receive the proper dose of oxcarbazepine could increase the chances of patients having a seizure and inadvertent consumption of ibuprofen may cause adverse reactions.

  • Company:
    Oxcarbazepine Tablets
Male Sexual Enhancement Products: Immediate Public Notification: Undeclared Drug Ingredients
06/03/2014 Medical Recall

Risk of interaction with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels.

  • Company:
    Eyeful
Reumofan Plus: Recall - Undeclared Drug Ingredient
03/14/2014 Medical Recall

UPDATED 03/14/2014. Pain Free by Nature is voluntarily recalling all lots of Reumofan Plus Tablets. Originally posted 06/01/2012.

  • Company:
    Reumofan Plus
Nizoral (ketoconazole): Drug Safety Communication - Potentially Fatal Liver Injury, Risk of Drug Interactions and Adrenal Gland Problems
07/26/2013 Medical Recall

Nizoral tablets should be used only for the treatment of certain life-threatening mycoses when the potential benefits outweigh the risks, and alternative therapeutic options are not available or tolerated.

  • Category
    Pharmacology